27885-92-3

Basic information

• Product Name: Imidocarb
• Synonyms: IMIDOCARB;1,3-Bis[3-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]urea;3,3’-di-2-imidazolin-2-yl-carbanilid;n,n’-bis(3-(4,5-dihydro-1h-imidazol-2-yl)phenyl)-ure;n,n’-bis(3-(4,5-dihydro-1h-imidazol-2-yl)phenyl)urea;N,N’-Bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea;1,3-Bis[3-(4,5-dihydro-1H-Imid;carbesia
• CAS NO: 27885-92-3
• Molecular Formula: C₁₉H₂₀N₆O
• Molecular Weight: 348.4
• EINECS: 248-711-7
• Product Categories: API
• Mol File: 27885-92-3.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 677.1oC at 760 mmHg
• Flash Point: 363.3oC
• Appearance: white powder
• Density: 1.39 g/cm³
• Vapor Pressure: 2.94E-19mmHg at 25°C
• Storage Temp.: Room Temperature
• Solubility: DMSO (Slightly), Methanol (Slightly, Heated)
• PKA: 13.81±0.70(Predicted)
• CAS DataBase Reference: Imidocarb(CAS DataBase Reference)
• NIST Chemistry Reference: Imidocarb(27885-92-3)
• EPA Substance Registry System: Imidocarb(27885-92-3)

Safety Data

• Hazardous Substances Data: 27885-92-3(Hazardous Substances Data)

Usage

Uses

Imidocarb is a urea derived antiprotozoal agent used in veterinary medicine for the treatment of infection with babesia and other parasites.

InChI:InChI=1/C19H20N6O.2C3H6O2/c26-19(24-15-5-1-3-13(11-15)17-20-7-8-21-17)25-16-6-2-4-14(12-16)18-22-9-10-23-18;2*1-2-3(4)5/h1-6,11-12H,7-10H2,(H,20,21)(H,22,23)(H2,24,25,26);2*2H2,1H3,(H,4,5)

Upstream product

• 32315-10-9 bis(trichloromethyl) carbonate 
• 94086-79-0 2-(3-aminophenyl)imidazoline 
• 618-95-1 methyl 3-nitrobenzoate 
• 57-13-6 urea 
• 31659-42-4 2-(3-nitrophenyl)-2-imidazoline 
• 619-24-9 3-nitrobenzonitrile 

Downstream Products

• 55750-06-6 imidocarb dipropionate 

Relevant articles and documents

Preparation method of imidocarb dipropionate and intermediate thereof

The invention discloses a preparation method of imidocarb dipropionate and an intermediate thereof and belongs to the technical field of chemical pharmacy. According to the method, m-nitrobenzonitrilereacts with ethylenediamine with sodium sulfide taken as a catalyst; palladium on carbon-ammonium formate reduction is performed; a product and urea are subjected to condensation reaction, so that imidazole phenylurea dihydrochloride can be obtained; dissociated imidazole phenylurea reacts with propionic acid, so that the imidazole phenylurea dipropionate can be obtained. The method has the advantages o reduced wastes, cheap and easily available raw materials, simple operation, high product yield, simple process operation and high safety, and is suitable for industrial production.